BMP2, transcriptionally regulated by GATA6, accelerates the proliferation and invasion of lung squamous carcinoma cells
Abstract
Lung squamous cell carcinoma (LUSC) has a high mortality rate, creating an urgent need to identify novel therapeutic targets. Aberrant expression of bone morphogenetic protein 2 (BMP2) is associated with the progression of several cancers. Previous reports demonstrated that BMP2 is highly expressed in tumor tissues and serum of patients with non-small cell lung cancer (NSCLC). However, the pathological roles and mechanisms of BMP2 in LUSC progression, and the mechanism underlying the overexpression of BMP2 remain to be elucidated. In this study, we found that a high level of BMP2 is correlated with poor prognosis in patients with LUSC, and that BMP2 promotes the growth and metastasis of LUSC cells in vitro and in vivo by activating the MAPK-ERK1/2 signaling pathway. The expression of BMP2 is transcriptionally repressed by the transcription factor GATA6. In conclusion, our findings demonstrate that BMP2 may serve as a potential therapeutic target for the treatment of LUSC.
Related
- Hydrodynamic flow in the gut hinders the fixation of beneficial mutants but accelerates their invasion
- Alcohol Promotes ER+ Breast Cancer Cell Proliferation and Invasion Through the Upregulation of Neuregulin 1-Mediated ER-ErbB3 Crosstalk
- Preoperative systemic immunothrombotic state class is associated with microvascular invasion and early recurrence after curative resection for hepatocellular carcinoma
- Matrix‑stiffness‑triggered mechanotransduction fuels hepatocellular carcinoma proliferation through Hippo‑orchestrated ANKRD1‑PRMT5 complex‑driven arginine methylome remodeling
- Dengue Virus Serotype 2 Infection Transcriptionally Reprograms Host Neutrophils to Establish an Immunosuppressive Microenvironment in Mice
BibTeX
@article{yang2026bmp2,
title = {{BMP2, transcriptionally regulated by GATA6, accelerates the proliferation and invasion of lung squamous carcinoma cells}},
author = {Hua Yang and Changhua Huang and Hailong Wang and Limin Chen},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117882},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03265-7},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - BMP2, transcriptionally regulated by GATA6, accelerates the proliferation and invasion of lung squamous carcinoma cells
AU - Hua Yang
AU - Changhua Huang
AU - Hailong Wang
AU - Limin Chen
PY - 2026
DA - 2026/10/19
JO - iScience
DO - 10.1016/j.isci.2026.117882
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03265-7
AB - Lung squamous cell carcinoma (LUSC) has a high mortality rate, creating an urgent need to identify novel therapeutic targets. Aberrant expression of bone morphogenetic protein 2 (BMP2) is associated with the progression of several cancers. Previous reports demonstrated that BMP2 is highly expressed in tumor tissues and serum of patients with non-small cell lung cancer (NSCLC). However, the pathological roles and mechanisms of BMP2 in LUSC progression, and the mechanism underlying the overexpression of BMP2 remain to be elucidated. In this study, we found that a high level of BMP2 is correlated with poor prognosis in patients with LUSC, and that BMP2 promotes the growth and metastasis of LUSC cells in vitro and in vivo by activating the MAPK-ERK1/2 signaling pathway. The expression of BMP2 is transcriptionally repressed by the transcription factor GATA6. In conclusion, our findings demonstrate that BMP2 may serve as a potential therapeutic target for the treatment of LUSC.
SN - 2589-0042
ER -